<p>A) The binding of β2GPI in serum to cardiolipin-coated surface in the absence (triangles) and in the presence (circles) of anti-β2GPI antibodies. B) Inhibition of the binding of β2GPI in human serum to cardiolipin in the presence of anti-β2GPI antibodies by the dimeric inhibitor A1-A1 (circles) and monomeric inhibitor A1 (triangles). Fit to one-site binding and inhibition models was performed on the raw data. To facilitate comparison, the measured OD<sub>405</sub> values and the binding curves were normalized to the maximum binding obtained from the fit.</p
<p>Various concentrations of the Fc or the F(ab’)<sub>2</sub> fragment of human IgG were mixed with ...
<p>The ability of human serum antibodies to bind to the mimotopic peptides selected with anti-VSG mo...
Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (serpin) that regulates fib...
<p>Inhibition curves measured for the dimeric inhibitor A1-A1 (circles) and monomeric inhibitor A1 (...
<p>A) The binding of β2GPI-DV to cardiolipin in the absence (triangles) and in the presence (circles...
<p>The purified β2GPI bound to cardiolipin in the absence of anti-β2GPI antibody with increasing amo...
<p>Inhibition of the binding of β2GPI-DV by A1 (circles); inhibition of the binding of β2GPI in seru...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
<p>A) Addition of 600μg GPGRAPI peptide (p<0,01), but not a control peptide significantly decreases ...
<p>(a) The plot of 5 sec. equilibrium. The maximal binding ratio of the control group was 16% and th...
<p><b>(A)</b> AB0041, AB0046, and GS-5745 demonstrate noncompetitive inhibition of MMP9: Antibody-me...
Antibodies play a critical role in the immune system to recognize and defend the body from antigens....
<p>(A) The binding activity of full-length mAb-3F6 to GP was evaluated in ELISA experiments, where a...
&-Glycoprotein I (f3,GPI) is a phospholipid-binding serum protein with anticoagulant properties....
<p>Various concentrations of the Fc or the F(ab’)<sub>2</sub> fragment of human IgG were mixed with ...
<p>The ability of human serum antibodies to bind to the mimotopic peptides selected with anti-VSG mo...
Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (serpin) that regulates fib...
<p>Inhibition curves measured for the dimeric inhibitor A1-A1 (circles) and monomeric inhibitor A1 (...
<p>A) The binding of β2GPI-DV to cardiolipin in the absence (triangles) and in the presence (circles...
<p>The purified β2GPI bound to cardiolipin in the absence of anti-β2GPI antibody with increasing amo...
<p>Inhibition of the binding of β2GPI-DV by A1 (circles); inhibition of the binding of β2GPI in seru...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an auto...
<p>A) Addition of 600μg GPGRAPI peptide (p<0,01), but not a control peptide significantly decreases ...
<p>(a) The plot of 5 sec. equilibrium. The maximal binding ratio of the control group was 16% and th...
<p><b>(A)</b> AB0041, AB0046, and GS-5745 demonstrate noncompetitive inhibition of MMP9: Antibody-me...
Antibodies play a critical role in the immune system to recognize and defend the body from antigens....
<p>(A) The binding activity of full-length mAb-3F6 to GP was evaluated in ELISA experiments, where a...
&-Glycoprotein I (f3,GPI) is a phospholipid-binding serum protein with anticoagulant properties....
<p>Various concentrations of the Fc or the F(ab’)<sub>2</sub> fragment of human IgG were mixed with ...
<p>The ability of human serum antibodies to bind to the mimotopic peptides selected with anti-VSG mo...
Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor (serpin) that regulates fib...